Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda Seeks 10-Fold Jump in China Sales by 2015, Hasegawa Says
Bloomberg
Wed, 09/22/10 - 09:58 am
Tags:
Takeda, China
FDA reviewing safety of Actos diabetes drug
MSNBC
Sat, 09/18/10 - 11:28 am
Tags:
Actos, diabetes, Takeda
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Tags:
Arena Pharmaceuticals, obesity, Takeda, Orexigen, Contrave, Abbott Laboratories, Meridia, Qnexa, Vivus
Alnylam Evenly Poised
Yahoo/Zacks.com
Fri, 09/10/10 - 08:15 am
Tags:
Alnylam, Novartis, Biogen Idec, Roche, Isis Pharmaceuticals, Cubist Pharmaceuticals, Takeda, earnings
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
Tags:
diet drugs, biotech, Arena Pharmaceuticals, Dendreon, Provenge, Exelixis, Vivus, Orexigen, Takeda, Contrave, Martek
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thu, 09/2/10 - 08:18 am
Tags:
Orexigen, Takeda, obesity, Contrave, partnerships
Takeda's Actos Has Same Heart Risks as Glaxo's Avandia, Researchers Find
Bloomberg
Wed, 08/25/10 - 07:53 am
Tags:
diabetes, Takeda, Actos, GSK, Avandia
Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg
Thu, 08/19/10 - 10:33 am
Tags:
Takeda, diabetes, Actos, generics
Affymax Lives to Fight Another Day
Motley Fool
Mon, 08/9/10 - 11:06 am
Tags:
Affymax, anemia, Takeda, Amgen
A Faster Pathway to Drug Approvals
Motley Fool
Sun, 08/1/10 - 02:26 pm
Tags:
Europe, FDA, drug approvals, AMA, Eli Lilly, Takeda, Pfizer, Eisai, Epix
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Tags:
Amylin, Bydureon, Byetta, diabetes, Novo Nordisk, Victoza, Merck, Januvia, Takeda, Actos, Onglyza, AstraZeneca
If Avandia falls, which diabetes meds fill the gap?
Fierce Pharma
Wed, 07/14/10 - 12:09 pm
Tags:
diabetes, GSK, Avandia, Actos, Takeda, Merck, Januvia, Novo Nordisk, Victoza, Eli Lilly, Byetta, Amylin, Onglyza, AstraZeneca, Bristol-Myers Squibb
Affymax Sell-Off: Did Investors Overreact?
Seeking Alpha
Thu, 07/8/10 - 09:27 am
Tags:
Affymax, Amgen, Takeda, EPO, Epogen, Micera, Roche, investors
Takeda Allocates $1.7 Billion for Product Purchases Over Next Three Years
Bloomberg
Thu, 07/8/10 - 08:57 am
Tags:
Takeda, M&A
Avandia, Heart Attacks & An Upcoming FDA Meeting
Pharmalot
Mon, 06/28/10 - 01:43 pm
Tags:
Avandia, heart attacks, GSK, diabetes, FDA, Actos, Takeda
In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone
Yahoo/BusinessWire
Sun, 06/27/10 - 11:07 am
Tags:
Januvia, Merck, pioglitazone, diabetes, type 2 diabetes, Actos, Takeda
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
BNET Pharma
Tue, 06/22/10 - 12:31 pm
Tags:
Amgen, Hematide, anemia, Affymax, Takeda
Takeda, CanBas: Ended Joint Study On Cancer Drug
Nikkei,com, Japan
Thu, 06/17/10 - 10:12 am
Tags:
Takeda, CanBas, lung cancer
Nexium, Protonix Linked to Bone Fractures, FDA Says
Bloomberg
Wed, 05/26/10 - 08:54 am
Tags:
fractures, Nexium, Protonix, Prevacid, AstraZeneca, Takeda, Pfizer, proton pump inhibitors
Takeda, Astellas Trim Costs as Generics Hurt Profit
Bloomberg
Thu, 05/13/10 - 06:52 am
Tags:
Takeda, Astellas, generics, layoffs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.